Fiduciary Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$773K Buy
6,015
+1,485
+33% +$174K 0.09% 138
2026
Q1
$545K Sell
4,530
-2,852
-39% -$329K 0.07% 162
2025
Q4
$777K Buy
7,382
+133
+2% +$12.5K 0.11% 124
2025
Q3
$608K Sell
7,249
-18
-0.2% -$1.48K 0.1% 132
2025
Q2
$595K Buy
7,267
+521
+8% +$41.4K 0.11% 127
2025
Q1
$523K Sell
6,746
-125
-2% -$11.7K 0.11% 121
2024
Q4
$682K Buy
6,871
+289
+4% +$29.8K 0.15% 95
2024
Q3
$714K Buy
6,582
+267
+4% +$31.7K 0.16% 81
2024
Q2
$792K Buy
+6,315
New +$813K 0.19% 73

Other funds holding MRK

Fiduciary Financial Group's MRK Position: Q2 2026 in Review

Fiduciary Financial Group increased its Merck (MRK) stake by 33% in Q2 2026, buying an estimated $174K and bringing the position to 6,015 shares worth $773K. The position accounts for 0.09% of the portfolio, ranked #138.

Fiduciary Financial Group first reported a position in MRK in Q2 2024 and has held it in 9 quarters since. The position peaked at $792K in Q2 2024. 1,859 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Fiduciary Financial Group held 6,015 shares of Merck worth $773K as of Q2 2026.
  • Fiduciary Financial Group bought 1,485 Merck shares in Q2 2026, an estimated $174K.
  • Merck made up 0.09% of Fiduciary Financial Group's portfolio in Q2 2026, its #138 holding.
  • Fiduciary Financial Group first reported a position in Merck in Q2 2024 and has held it in 9 quarters since.
  • Fiduciary Financial Group's Merck position peaked at $792K in Q2 2024.
  • 1,859 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Fiduciary Financial Group's 13F filing for Q2 2026, filed 10 Jul 2026.